Quest Diagnostics (DGX) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.23 per share a year ago.

Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand

08:03am, Tuesday, 10'th Feb 2026

Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street estimates after beating expectations for fourth-quarter results on strong demand for its diagnostic tests.

Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share

06:47am, Tuesday, 10'th Feb 2026

Fourth quarter revenues of $2.81 billion, up 7.1% from 2024 Fourth quarter reported diluted earnings per share ("EPS") of $2.18, up 11.8% from 2024; and adjusted diluted EPS of $2.42, up 8.5% from 202

Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization

06:33am, Tuesday, 10'th Feb 2026

SECAUCUS, N.J., Feb. 10, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the Company's Board of Directors h

Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings

10:46am, Friday, 06'th Feb 2026

DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and consumer testing.

Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term

10:46am, Friday, 06'th Feb 2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

10:40am, Thursday, 05'th Feb 2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX)

02:38am, Thursday, 05'th Feb 2026

Daxor (NASDAQ: DXR - Get Free Report) and Quest Diagnostics (NYSE: DGX - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on th

Quest Diagnostics (DGX) Expected to Announce Quarterly Earnings on Tuesday

01:02am, Tuesday, 03'rd Feb 2026

Quest Diagnostics (NYSE: DGX - Get Free Report) is expected to announce its Q4 2025 results before the market opens on Tuesday, February 10th. Analysts expect the company to announce earnings of $2.36

Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

08:52am, Monday, 02'nd Feb 2026

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX),

Truist Financial Corp Decreases Stake in Quest Diagnostics Incorporated $DGX

05:28am, Monday, 02'nd Feb 2026

Truist Financial Corp cut its holdings in shares of Quest Diagnostics Incorporated (NYSE: DGX) by 19.3% during the third quarter, according to its most recent disclosure with the Securities and Exchan

Quest Diagnostics Incorporated (NYSE:DGX) Receives Consensus Rating of “Moderate Buy” from Analysts

02:00am, Monday, 02'nd Feb 2026

Quest Diagnostics Incorporated (NYSE: DGX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the sixteen research firms that are currently covering the firm, MarketBeat

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by